Mark Rush
Advertisement
Mark is a partner and associate in Kirkpatrick & Lockhart, www.kl.com, a national law firm experienced in complex commercial litigation, intellectual property enforcement, and regulatory practice
Articles by Mark Rush
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
4
How Pharma is Adjusting Strategies for Changing Dynamics at FDA
5